{
    "2021-03-15": [
        [
            {
                "time": "",
                "original_text": "医药行业周报：胰岛素、精麻药品专项带量采购启动在即",
                "features": {
                    "keywords": [
                        "医药行业",
                        "胰岛素",
                        "精麻药品",
                        "带量采购"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "生物医药行业周报：医药估值溢价率低于历史均值 短期建议关注业绩确定性强的标的",
                "features": {
                    "keywords": [
                        "生物医药",
                        "估值溢价率",
                        "历史均值",
                        "业绩确定性"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本概念股普遍调整，泰格医药、甘李药业、凯莱英、金域医学领跌",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "泰格医药",
                        "甘李药业",
                        "凯莱英",
                        "金域医学"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "浙商证券给予凯莱英买入评级，凯莱英深度报告：差异化优势加速体现的CDMO龙头",
                "features": {
                    "keywords": [
                        "浙商证券",
                        "凯莱英",
                        "买入评级",
                        "CDMO龙头"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}